Immunovia AB
IMMNOV
Rank in Stocks
#33921
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Share Price
$0.00925939
Market Cap
$6.23M
Change (1 day)
2.73%
Change (1 year)
-73.18%
Country
SE
Trade Immunovia AB (IMMNOV)
Category
Healthcare
P/S ratio for Immunovia AB (IMMNOV)
P/S ratio as of 2026 TTM: 0
According to Immunovia AB latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Immunovia AB from 2026 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 5.37 | - |
US
|
|
| 6.29 | - |
US
|
|
| 21.02 | - |
US
|
|
| - | - |
CN
|
|
| 6.67 | - |
US
|
